These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4436787)

  • 1. Excretion of probenecid and its metabolites in bile and urine of rats.
    Conway WD; Melethil S
    J Pharm Sci; 1974 Oct; 63(10):1551-4. PubMed ID: 4436787
    [No Abstract]   [Full Text] [Related]  

  • 2. Mass spectral identification of probenecid metabolites in rat bile.
    Guarino AM; Conway WD; Fales HM
    Eur J Pharmacol; 1969 Nov; 8(2):244-52. PubMed ID: 5365271
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolism of probenecid in man.
    Dayton PG; Perel JM
    Ann N Y Acad Sci; 1971 Jul; 179():399-402. PubMed ID: 5285384
    [No Abstract]   [Full Text] [Related]  

  • 4. A gas chromatographic assay for probenecid and its metabolites in biological fluids.
    Conway WD; Melethil S
    J Chromatogr; 1975 Dec; 115(1):222-7. PubMed ID: 1202064
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification and renal excretion of probenecid metabolites in man.
    Perel JM; Cunningham RF; Fales HM; Dayton PG
    Life Sci I; 1970 Dec; 9(23):1337-43. PubMed ID: 5493001
    [No Abstract]   [Full Text] [Related]  

  • 6. Biliary excretion of probenecid and its glucuronide.
    Guarino AM; Schanker LS
    J Pharmacol Exp Ther; 1968 Dec; 164(2):387-95. PubMed ID: 5699099
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of phenobarbital on biliary excretion of organic acids in male and female rats.
    Hart LG; Guarino AM; Adamson RH
    Am J Physiol; 1969 Jul; 217(1):46-52. PubMed ID: 5785898
    [No Abstract]   [Full Text] [Related]  

  • 8. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats.
    Mays DC; Dixon KF; Balboa A; Pawluk LJ; Bauer MR; Nawoot S; Gerber N
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1261-70. PubMed ID: 1762074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the biliary excretion mechanisms of drugs. 3. Active transport of glucuronides into bile in rats.
    Uesugi T; Ikeda M; Kanei Y
    Chem Pharm Bull (Tokyo); 1974 Feb; 22(2):433-8. PubMed ID: 4845550
    [No Abstract]   [Full Text] [Related]  

  • 10. Probenecid disposition by parallel Michaelis-Menten and dose-dependent pseudo-first-order processes.
    Ho JC; Conway WD; Melethil S
    J Pharm Sci; 1986 Jul; 75(7):664-8. PubMed ID: 3761166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interindividual variation in the capacity-limited renal glucuronidation of probenecid by humans.
    Vree TB; Van Ewijk-Beneken Kolmer EW; Wuis EW; Hekster YA; Broekman MM
    Pharm World Sci; 1993 Oct; 15(5):197-202. PubMed ID: 8257956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the biliary excretion mechanism of drugs. I. Biliary excretion of azo dyes in the rat.
    Ikeda M; Uesugi T
    Biochem Pharmacol; 1973 Nov; 22(21):2743-51. PubMed ID: 4763608
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 17 alpha-ethinylestradiol on the biliary metabolites of 17 beta-[6,7-3H2]estradiol in the rat.
    Watanabe H
    Biochim Biophys Acta; 1971 Mar; 231(2):399-405. PubMed ID: 5554907
    [No Abstract]   [Full Text] [Related]  

  • 14. Diurnal variations in excretion of corticosteroid metabolites in bile from male and female rats.
    Begue RJ; Gustafsson JA; Gustafsson SA
    J Steroid Biochem; 1973 Jul; 4(4):393-400. PubMed ID: 4747983
    [No Abstract]   [Full Text] [Related]  

  • 15. Contribution of the human kidney to the metabolic clearance of drugs.
    Vree TB; Hekster YA; Anderson PG
    Ann Pharmacother; 1992 Nov; 26(11):1421-8. PubMed ID: 1477449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on the disposition of probenecid in patients receiving allopurinol.
    Tjandramaga TB; Cucinell SA; Israili ZH; Perel JM; Dayton PG; Yü TF; Gutman AB
    Pharmacology; 1972; 8(4):259-72. PubMed ID: 4572009
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data.
    Ueda K; Kato Y; Komatsu K; Sugiyama Y
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1036-43. PubMed ID: 11356926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pharmacokinetics of probenecid in the neonatal period].
    Balogh A; Bräunlich H; Splinter FK; Zaumseil J
    Pharmazie; 1978 Jun; 33(6):365-9. PubMed ID: 28537
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined GC and high resolution mass spectrometric determination of probenecid.
    Sabih K; Klaassen CD; Sabih K
    J Pharm Sci; 1971 May; 60(5):745-8. PubMed ID: 5125775
    [No Abstract]   [Full Text] [Related]  

  • 20. Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat.
    Savina PM; Brouwer KL
    Drug Metab Dispos; 1992; 20(4):496-501. PubMed ID: 1356724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.